Almost nothing sold for damaged nails has been tested against a placebo. The category runs on before-and-after photographs, protein-sounding ingredient names, and the reasonable assumption that nobody will hold a nail treatment to the standard we hold a face serum. So it is genuinely strange to find that this particular bottle — seven ingredients, no fragrance, sold next to the corn plasters — contains a solution that went through a 493-patient randomised, double-blind, placebo-controlled trial and published the results. It started as K101 in Sweden, sold across Europe under other names for years, and arrived in American pharmacies inside the Kerasal nail line. The formula's dullness is its entire personality: propylene glycol, urea, glycerin, lactic acid, water, a pH adjuster and a chelator. That is the whole list.
The logic behind those four working ingredients is worth understanding, because it explains both what this does and what it stubbornly refuses to do. A nail plate is keratin compressed into something closer to a fingernail-shaped shell than to skin — dense, layered, and famously hostile to anything you paint on it. Propylene glycol leads the list because it is the only thing in the bottle capable of carrying the others into that shell. Urea, sitting second, breaks the hydrogen bonding that holds keratin fibres rigidly together, which is why a thickened toenail that used to resist clippers becomes filable within a couple of weeks. Lactic acid drops the pH and works on the crumbling, discolored keratin at the free edge, loosening what is already dying so it can be filed away. Glycerin is the sanity check — the one humectant preventing a formula of solvent and acid from leaving the nail fold parched after two months of daily use.
What that combination cannot do is repair anything. This is the part people get wrong, and it is not their fault, because the marketing for the whole category is built on the implication. The damaged section of a nail is dead tissue; it will look better only insofar as this softens and sheds its worst layers, and it will look genuinely normal only when it has grown off the end of your finger. That is roughly two to three months for a fingernail and anywhere from six to twelve for a big toenail, which grows at about a millimetre a month and does not care about your schedule. The brand's own instructions say three to six months. Believe them.
Using it is the least demanding part. The liquid comes off a stubby flat brush, spreads like water, and flashes dry in under a minute to a film you cannot see or feel. There is no smell — not even the acetone-adjacent sharpness most nail treatments carry — and no sting unless it seeps somewhere it shouldn't, in which case you get a brief warmth around the fold rather than genuine burning. Twice daily for the first week, once daily thereafter. A small bottle covers a few nails for around three months, and a single problem toenail can stretch it well past six.
The non-negotiable is bare nails. Polish, gel, even a clear base coat blocks penetration completely, so committing to this means committing to unmanicured hands for as long as the treatment runs. For anyone whose nails were wrecked by gels in the first place — which is a large share of the people reaching for this — that is a genuinely unwelcome trade, and it is the reason most abandoned bottles get abandoned. There is a certain justice in it: the fix for what the manicure did requires skipping the manicure.
On results, the honest shape is a fast cosmetic win followed by a long dull middle. The surface stops looking chalky and starts reflecting light within a week or two, which feels like progress and is largely just smoothing. Then very little visibly happens for a month or more while new plate creeps forward. People who quit at week five quit exactly when nothing appears to be happening, and they quit having received almost none of the benefit they paid for. Anyone who has ever abandoned a retinoid in month two knows this particular flavour of impatience intimately.
The fungus question deserves directness. This is not a prescription antifungal and should not be treated as one. The published work does show higher mycological cure than placebo in nails less than half involved, and there is measurable in vitro activity against the usual dermatophyte at high concentrations — a better evidence base than essentially any tea-tree-and-hope competitor. But a nail that is painful, lifting, spreading, or attached to a diabetic foot needs a clinician, not a pharmacy shelf. Where this earns its place is the middle ground: a nail that has already been treated, or a nail damaged by something other than infection entirely, that simply looks awful and needs the wreckage cleared while it regrows.
At around eighteen dollars for thirteen millilitres, the sticker looks steep next to the bottle. Spread across a three-month course it is a few dollars a month, which is fair for something with actual trial data behind it — and considerably cheaper than the salon appointments that often caused the problem. What you are really paying with is patience and vanity, in that order. If you have both to spare, this is one of the few things in the nail aisle that deserves the shelf space it occupies.
